Clinical Trial Update: MARIGOLD Study: A Study of RO4917523 Versus Placebo as Adjunctive Therapy in Patients With Major Depressive Disorder and an Inadequate Response to Ongoing Antidepressant Therapy [Phase 2]

View source ↗

Summary

MARIGOLD is a Phase 2 trial comparing RO4917523 to placebo as adjunctive therapy for major depressive disorder with inadequate response to ongoing antidepressan…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Major Depressive Disorder

Drugs mentioned

• RO4917523

Snippet

Sponsor: Hoffmann-La Roche | Conditions: Major Depressive Disorder | Phase 2 | Status: COMPLETED